A prospective study of SCA3 gait ataxia described through a markovian method

Neuroepidemiology

Volumn 34, Issue 3, 2010, Pages 163-170

  Camey, Suzi ^a   Jardim, Laura Bannach ^a,b   Kieling, Christian ^b   Saute, Jonas Alex Morales ^b   Vigo, Álvaro ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Degenerative disorders; Longitudinal study; Machado Joseph disease; Markov chain; Polyglutamine diseases; SCA3

Indexed keywords

ADULT; ARTICLE; ATAXIA; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PROSPECTIVE STUDY; SCORING SYSTEM; SPINOCEREBELLAR DEGENERATION;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACHADO-JOSEPH DISEASE; MALE; MARKOV CHAINS; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 75549083826     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000279333     Document Type: Article

References (17)

1. Zilber N, Manor O, Inzelberg R, Kahana E, Korczyn AD: A statistical method for quantitative evaluation of the progression of chronic diseases: the mean score graph (MSG). Stat Med 1998; 17: 2395-2403. (Pubitemid 28482681)
2. Zilber N, Inzelberg R, Kahana E, Korczyn AD: Natural course of idiopathic torsion dystonia among Jews. Neuroepidemiology 1994; 13: 195-201. (Pubitemid 24229133)
3. Anderson TW, Goodman A: Statistical inference about Markov chains. Ann Math Stat 1957; 28: 89-110.
4. Grinstead CM, Snell JL: Introduction to Probability , ed 2, rev. Providence, AMS, 1997, pp 155-178.
5. Takiyama Y, Nishizawa M, Tanaka H, et al: The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet 1993; 4: 300-304. (Pubitemid 23205181)
6. Kawaguchi Y, Okamoto T, Taniwaki M, et al: CAG expansions in a novel gene for Machado- Joseph disease at chromosome 14q32.1. Nat Genet 1994; 8: 221-228. (Pubitemid 24338732)
7. Bauer PO, Kotliarova SE, Matoska V, et al: Fluorescent multiplex PCR - fast method for autosomal dominant spinocerebellar ataxias screening. Genetika 2005; 41: 830-837. (Pubitemid 44710708)
8. Prestes PR, Saraiva-Pereira ML, Silveira I, Sequeiros J, Jardim LB: Machado-Joseph disease enhances genetic fitness: a comparison between affected and unaffected women and between MJD and the general population. Ann Hum Genet 2007; 72: 57-64.
9. Kieling C, Rieder CR, Silva AC, Saute JA, Cecchin CR, Monte TL, Jardim LB: A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3). Eur J Neurol 2008; 15: 371-376. (Pubitemid 351422388)
10. Klockgether T, Ludtke R, Kramer B, et al: The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 1998; 121: 589-600. (Pubitemid 28162122)
11. Maciel P, Gaspar C, DeStefano AL, et al: Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet 1995; 57: 54-61.
12. Maruyama H, Nakamura S, Matsuyama Z, et al: Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum Mol Genet 1995; 4: 807-812.
13. Schols L, Amoiridis G, Buttner T, Przuntek H, Epplen JT, Riess O: Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol 1997; 42: 924-932. (Pubitemid 28008424)
14. Schols L, Bauer P, Schmidt T, Schulte T, Riess O: Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291-304. (Pubitemid 38510200)
15. Kieling C, Prestes PR, Saraiva-Pereira ML, Jardim LB: Survival estimates for patients with Machado-Joseph disease (SCA3). Clin Genet 2007; 72: 543-545. (Pubitemid 350131060)
16. Schmitz-Hubsch T, Coudert M, Bauer P, et al: Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 2008; 71: 982-989.
17. Franca MC Jr, D'Abreu A, Nucci A, Cendes F, Lopes-Cendes I: Progression of ataxia in patients with Machado-Joseph disease. Mov Disord 2009;24:1387-1390.